通过质谱技术在膜性肾病和膜性狼疮性肾炎中发现七种新型推定抗原
研究对142例PLA2R/THSD7A/EXT1/NELL1四联阴性膜性肾病和278例已知抗原类型病例的活检组织免疫复合物进行质谱分析,发现FCN3、CD206、EEA1、SEZ6L2、NPR3、MST1和VASN七种推定抗原,并在165例PLA2R阴性膜性肾病和142例膜性狼疮性肾炎连续病例中筛查频率,各标志物阳性率低于1%至4.9%。
要点
- 在四联阴性膜性肾病活检免疫复合物中鉴定出七种推定抗原:FCN3、CD206、EEA1、SEZ6L2、NPR3、MST1和VASN。
- 各抗原在连续病例中的阳性频率范围从低于1%至4.9%,NPR3和CD206仅在指示病例中阳性。
- 所有病例均显示IgG与免疫沉积物共定位,由于抗原数量多,仅靠免疫组化分型PLA2R阴性膜性肾病或膜性狼疮性肾炎已不实用,需要多重方法进行亚型分析。
核心结论
- 在膜性肾病和膜性狼疮性肾炎中新发现七种推定抗原,由于抗原数量多,仅靠免疫组化分型PLA2R阴性膜性肾病或膜性狼疮性肾炎已不实用,需要多重方法进行亚型分析。
研究设计与样本
- 从Arkana Laboratories病例档案中识别四种抗原(PLA2R、THSD7A、EXT1/2、NELL1)阴性的膜性肾病患者,对142例四联阴性病例和278例已知抗原类型病例的冷冻活检组织通过蛋白G免疫沉淀回收免疫复合物,并进行质谱分析。
- 通过石蜡免疫荧光和与IgG在免疫沉积物中的共定位确认推定抗原。
- 对165例PLA2R阴性膜性肾病和142例膜性狼疮性肾炎活检连续病例进行筛查,以确定每种潜在抗原的频率。
主要发现
- 在膜性肾病患者活检免疫复合物中发现七种推定抗原:FCN3、CD206、EEA1、SEZ6L2、NPR3、MST1和VASN。
- 这些蛋白的肽段在278例已知抗原类型病例中未富集。
- 每个新靶标检测到3至30个独特肽段。
- 通过连续病例系列染色确定各标志物频率范围为低于1%至4.9%。
- NPR3和CD206仅在指示病例中阳性,所有病例均显示IgG在免疫沉积物中共定位。
关键数值与推荐
- 各生物标志物频率范围为低于1%至4.9%。
- 每个新靶标检测到3至30个独特肽段。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple autoantigens have been identified in membranous nephropathy (MN) by tissue-based proteomics. However, antigenic targets of disease are unknown for over 10% of patients with MN and over half of those with membranous lupus nephritis (MLN). Here, we identified multiple new targets in PLA2R-/THSD7A-/EXT-/NELL1-quadruple negative MN biopsies through mass spectrometry of immune complexes recovered from biopsy tissue of patients with MN. Patients with MN negative for these four antigens were identified from Arkana Laboratories case archives. Protein G immunoprecipitation recovered immune complexes from frozen biopsy tissue from 142 quadruple-negative cases and 278 cases of known antigen type, followed by interrogation by mass spectrometry. Potential putative antigens were confirmed through paraffin immunofluorescence and co-localization with IgG within immune deposits. Consecutive series of 165 cases of PLA2R-negative MN and 142 MLN biopsies were screened to determine the frequency for each potential antigen. Seven putative antigens were discovered within immune complexes from biopsies of patients with MN including FCN3, CD206, EEA1, SEZ6L2, NPR3, MST1, and VASN. Peptides from these proteins were not enriched in the 278 cases of known antigen type. Between three to 30 unique peptides were detected for each new target. Frequencies of each biomarker, determined by staining consecutive case series, ranged from under 1 to 4.9%. NPR3 and CD206 were only positive in index cases. All cases showed co-localization of IgG within the immune deposits. Thus, seven putative antigens were newly identified in MN and MLN. Due to the number of antigens identified, it is becoming impractical to type PLA2R-negative MN or MLN cases through immunostaining alone. A multiplex approach is needed for subtyping of these diseases.
引用
- Caza TN, Storey AJ, Hassen SI, et al. Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry. Kidney Int. 2023. PMID: 36638888. doi:10.1016/j.kint.2023.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。